<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04528043</url>
  </required_header>
  <id_info>
    <org_study_id>PSS2018/EB3REA-NOVY/YB</org_study_id>
    <nct_id>NCT04528043</nct_id>
  </id_info>
  <brief_title>Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care Unit</brief_title>
  <acronym>EB3REA</acronym>
  <official_title>Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care Impact on the Mortality and Morbidity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is a lack of data whether colonization and infection with Enterobacteriaceae of the&#xD;
      third group (EB3) affect the outcomes for ICU patients. This study evaluated the effects of&#xD;
      EB3 colonization and infection on ICU mortality, ICU length of stay (LOS) and broad-spectrum&#xD;
      antibiotic exposure. We focused on the sub type Enterobacter regarding its a priori higher&#xD;
      risk of resistance.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">January 10, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>all cause mortality</measure>
    <time_frame>Day 180</time_frame>
    <description>Evaluation of the impact of colonization and/or infection with third group enterobacteriaceae on mortality during hospitalization and up to 180 day</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Resistance strains of sub type enterobacter</measure>
    <time_frame>DAY 90</time_frame>
    <description>Evaluation of number of resistant strains among Enterobacter subtype in comparison with other third group enterobacteriaceae</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">179</enrollment>
  <condition>Critically Ill</condition>
  <condition>Enterobacteriaceae Infections</condition>
  <condition>Antibiotic Resistant Infection</condition>
  <arm_group>
    <arm_group_label>critically ill patients</arm_group_label>
    <description>critically ill patients admitted in one of the 5 ICUs of the university hospital of Nancy during the year 2016 with documented third group enterobacteriaceae infection and/or colonization with third group enterobacteriaceae</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All adults (≥ 18 years-old) patients admitted in the participating ICUs with LOS ≥ 24 hours&#xD;
        during the study period were enrolled if they had presented a colonization and/or an&#xD;
        infection caused by an EB3 (Enterobacter cloacae, Enterobacter aerogenes, Morganella&#xD;
        morganii, Serratia marcescens, Hafnia alvei et Citrobacter freundii), from 1st January 2016&#xD;
        to 31th December 2016.&#xD;
&#xD;
        Participating ICUs of the university hospital of Nancy:&#xD;
&#xD;
          -  two Medical ICU&#xD;
&#xD;
          -  3 surgical ICU&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adults critically ill patients admitted to the the participating ICUs during the study&#xD;
             period&#xD;
&#xD;
          -  with colonization and/or infection with a third group enterobacteriacea&#xD;
&#xD;
          -  and with a lenght of stay &gt; 24h&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  minors patients&#xD;
&#xD;
          -  lenght of stay &lt; 24h&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Emmanuel NOVY</name>
      <address>
        <city>Vandoeuvre Les Nancy</city>
        <state>Lorraine</state>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>August 24, 2020</study_first_submitted>
  <study_first_submitted_qc>August 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 27, 2020</study_first_posted>
  <last_update_submitted>August 24, 2020</last_update_submitted>
  <last_update_submitted_qc>August 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Third group Enterobacteriaceae</keyword>
  <keyword>infection</keyword>
  <keyword>colonization</keyword>
  <keyword>resistance</keyword>
  <keyword>AMPc cephalosporinase</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Enterobacteriaceae Infections</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

